Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects

Clinica Chimica Acta

Volumn 413, Issue 5-6, 2012, Pages 537-543

  Ohtani, Rumiko ^a   Inazu, Akihiro ^a   Noji, Yoshihiro ^b   Wakasugi, Takanobu ^b   Miwa, Kenji ^c   Tada, Hayato ^a   Kawashiri, Masa aki ^a   Noguchi, Tohru ^a   Nohara, Atsushi ^a   Kobayashi, Junji ^a   Koizumi, Junji ^d   Yamagishi, Masakazu ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Fukui Prefectural Hospital   (Japan)

^c Ishikwa Prefectural Central Hospital   (Japan)

^d KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CETP; High density lipoprotein cholesterol; Hyperalphalipoproteinemia

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CHOLESTEROL BLOOD LEVEL; CHOLESTERYL ESTER TRANSFER PROTEIN GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF LIPOPROTEIN METABOLISM; FEMALE; FRAMESHIFT MUTATION; GENE; HETEROZYGOTE; HUMAN; HYPERALPHALIPOPROTEINEMIA; INDEL MUTATION; JAPANESE; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

AGED; ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHOLESTEROL ESTER TRANSFER PROTEINS; COS CELLS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; JAPAN; MIDDLE AGED; MUTATION; PEDIGREE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

EID: 84856233223     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.11.010     Document Type: Article

References (46)

1. Lamarche B., Uffelman K.D., Carpentier A., et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999, 103:1191-1199.
2. Pattnaik N.M., Montes A., Hughes L.B., Zilversmit D.B. Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim Biophys Acta 1978, 530:428-438.
3. Qiu X., Mistry A., Ammirati M.J., et al. Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat Struct Mol Biol 2007, 14:106-113.
4. Hogarth C.A., Roy A., Ebert D.L. Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Physiology 2003, 135:71-81.
5. Ha Y.C., Barter P.J. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol B 1982, 71:265-269.
6. Koizumi J., Mabuchi H., Yoshimura A., et al. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 1985, 58:175-186.
7. Inazu A., Brown M.L., Hesler C.B., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990, 323:1234-1238.
8. Takahashi K., Jiang X.C., Sakai N., et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest 1993, 92:2060-2064.
9. Inazu A., Jiang X.C., Haraki T., et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994, 94:1872-1882.
10. Mabuchi H., Inazu A. Human cholesteryl ester transfer protein in human HDL metabolism. High density lipoproteins, dyslipidemia, and coronary heart disease 2010, 95-101. Springer. E.J. Schaefer (Ed.).
11. Inazu A. Plasma cholesteryl ester transfer protein (CETP) in relation to human pathophysiology. The HDL Handbook 2010, 35-60. Biological functions and clinical implications, Elsevier B.V. T. Komoda (Ed.).
12. Kiyohara T., Kiriyama R., Zamma S., et al. Enzyme immunoassay for cholesteryl ester transfer protein in human serum. Clin Chim Acta 1998, 271:109-118.
13. Untergasser A., Nijveen H., Rao X., Bisseling T., Geurts R., Leunissen J.A.M. Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 2007, 35(Web Server issue):W71-W74.
14. Agellon L.B., Quinet E.M., Gillette T.G., Drayna D.T., Brown M.L., Tall A.R. Organization of the human cholesteryl ester transfer protein gene. Biochemistry 1990, 29:1372-1376.
15. Quinet E., Yang T.P., Marinos C., Tall A. Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. J Biol Chem 1993, 268:16891-16894.
16. Inazu A., Quinet E.M., Wang S., et al. Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein. Biochemistry 1992, 31:2352-2358.
17. Boussif O., Lezoualc'h F., Zanta M.A., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995, 92:7297-7301.
18. Gotoda T., Kinoshita M., Ishibashi S., et al. Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan. Arterioscler Thromb Vasc Biol 1997, 17:1376-1381.
19. Muhlrad D., Parker R. Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA 1999, 5:1299-1307.
20. van der Steeg W.A., Hovingh G.K., Klerkx A.H.E.M., et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians. J Lipid Res 2007, 48:674-682.
21. Boekholdt S.M., Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 2003, 44:1080-1093.
22. Inazu A., Nishimura Y., Terada Y., Mabuchi H. Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population. J Hum Genet 2001, 46:172-177.
23. Arai H., Yamamoto A., Matsuzawa Y., et al. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000 Serum Lipid Level Survey 2000 in Japan. J Atheroscler Thromb 2005, 12:240-250.
24. Edmondson A.C., Brown R.J., Kathiresan S., et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 2009, 119:1042-1050.
25. Vergeer M., Korporaal S.J.A., Franssen R., et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011, 364:136-145.
26. Yang X.P., Becker L.C., Becker D.M., et al. Mutations in scavenger receptor-BI/II result in a novel dyslipidemia, with increased HDL and lipoprotein(a) (Abstract). Circ Suppl 2008, 118:S-559.
27. Plengpanich W., Le Goff W., Poolsuk S., Julia Z., Guerin M., Khovidhunkit W. CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes. Atherosclerosis 2011, 216:370-373.
28. Nagano M., Yamashita S., Hirano K., et al. Point mutation (-69 G>A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. Arterioscler Thromb Vasc Biol 2001, 21:985-990.
29. Lloyd D.B., Reynolds J.M., Cronan M.T., et al. Novel variants in human and monkey CETP. Biochim Biophys Acta 2005, 1737:69-75.
30. Jap T.-S., Wu Y.-C., Tso Y.-C., Chiu C.-Y. A novel mutation in the intron 1 splice donor site of the cholesterol ester transfer protein (CETP) gene as a cause of hyperalphalipoproteinemia. Metabolism 2002, 51:394-397.
31. Calabresi L., Nilsson P., Pinotti E., et al. A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred. Atherosclerosis 2009, 205:506-511.
32. Funke H., Wiebusch H., Fuer L., Muntoni S., Schulte H., Assmann G. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol (Abstract). Circ Suppl 1994, 90:p23.
33. Ritsch A., Drexel H., Amann F.W., Pfeifhofer C., Patsch J.R. Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma. Arterioscler Thromb Vasc Biol 1997, 17:3433-3441.
34. Rhyne J., Ryan M.J., White C., Chimonas T., Miller M. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease. J Mol Med 2006, 84:647-650.
35. Nagano M., Yamashita S., Hirano K., et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay. J Lipid Res 2006, 43:1011-1018.
36. Arai T., Yamashita S., Sakai N., et al. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. J Lipid Res 1996, 37:2145-2154.
37. Takata K., Mishima Y., Shirahata H., Umemoto S., Toyota Y., Hiraoka A. A novel nonsense mutation of cholesteryl ester transfer protein gene and the clinical characterization of Japanese primary hyperalphalipoproteinamias (Abstract). Atheroscler Suppl 2003, 4:301.
38. Plengpanich W., Siriwong S., Khovidhunkit W. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia. Metabolism 2009, 58:1178-1184.
39. Teh E.M., Dolphin P.J., Breckenridge W.C., Tan M.H. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J Lipid Res 1998, 39:442-456.
40. Ramsbottom D., O'Neill A., Sexton D.M., Gafoor R.A., Bouchier-Hayes D., Croke D.T. The cholesteryl ester transfer protein (CETP) locus as a candidate gene in abdominal aortic aneurysm. Clin Genet 1997, 51:241-245.
41. Zheng K.-Q., Zhang S.-Z., Zhang L., Huang D.-J., Liao L.-C., Hou Y.-P. A novel missense mutation (L296Q) in cholesteryl ester transfer protein gene related to coronary heart disease. Acta Biochim Biophys Sin 2004, 36:33-36.
42. Thompson J.F., Reynolds J.M., Williams S.P., Wood L.S., Paciga S.A., Lloyd D.B. Frequency and function of CETP variants among individuals of Asian ancestry. Atherosclerosis 2009, 202:241-247.
43. Gotoda T., Kinoshita M., Shimano H., et al. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem Biophys Res Commun 1993, 194:519-524.
44. Sakai N., Santamarina-Fojo S., Yamashita S., Matsuzawa Y., Brewer H.B. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res 1996, 37:2065-2073.
45. Brown M.L., Inazu A., Hesler C.B., et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989, 342:448-451.
46. Cefalù A.B., Noto D., Magnolo L., et al. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia. Atherosclerosis 2009, 204:202-207.